Skip to main navigation
  • Newsroom
  • Get in Touch
  • LinkedIn
Editas Medicine logo
  • Research and Pipeline
  • CRISPR Gene Editing
  • For Patients
  • Who We Are
  • Join Our Team
  • Investors
  • Newsroom
  • Get in Touch
  • LinkedIn

Media & Investors

  • Overview
  • Press Releases
  • Events & Presentations
  • Corporate Governance
    • Documents & Charters
    • Management
    • Board of Directors
    • Committee Composition
    • Annual Meeting Materials
  • Financials & Filings
    • SEC Filings
    • Annual Reports
  • Stock Information
    • Stock Quote & Chart
  • Investor FAQs
  • Contact

Press Releases

Press Releases

Keyword Search

March 6, 2018
Editas Medicine Announces Fourth Quarter and Full Year 2017 Results and Update
February 28, 2018
Editas Medicine Supports Rare Disease Day® and Joins Global Movement to Raise Important Awareness for Rare Diseases
February 27, 2018
Editas Medicine to Host Conference Call Discussing Fourth Quarter and Full Year 2017 Corporate Update and Results
February 16, 2018
Editas Medicine Names Jessica Hopfield, Ph.D., to Board of Directors
February 8, 2018
Editas Medicine to Participate in Upcoming Investor Conferences
January 8, 2018
Editas Medicine Reports on Recent Progress and Announces “EM22” Five-year Goals at J.P. Morgan Healthcare Conference
January 3, 2018
Editas Medicine to Present at the 36th Annual J.P. Morgan Healthcare Conference

Pagination

  • First page « first
  • Previous page ‹ previous
  • Page 1
  • Page 2
  • Current page 3

>> Main navigation

  • Research and Pipeline
  • CRISPR Gene Editing
  • For Patients
  • Who We Are
  • Join Our Team
  • Investors

©Copyright 2026 Editas Medicine

>> Footer menu

  • Get in Touch
  • Investors
  • Privacy Policy
  • Terms of Use